DEA publishes final rule on continuity of care via telemedicine for veterans - American Academy of Sleep Medicine | AASM
DEA final rule on continuity of care via telemedicine for veterans, easing prescribing restrictions for controlled substances via telehealth for veterans under certain conditions.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers serving veterans should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective immediately upon publication in Federal Register; compliance expected within 30 days.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA final rule allows continued prescribing of controlled substances via telemedicine for veterans without an in-person visit, under specific continuity-of-care provisions.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers serving veterans
What you must do
Review and update telehealth prescribing protocols to align with new DEA rule for veteran patients; ensure compliance with documentation and patient relationship requirements.
Deadline
Effective immediately upon publication in Federal Register; compliance expected within 30 days.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis